Blood group antigens in differentiated thyroid neoplasms

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 11, 1998, Pages 957-965

  González Cámpora, Ricardo ^a   García Santana, Juan Angel ^a   Jordà I Heras, Maria Mercè ^b   Salaverri, Concepción Otal ^a   Vázquez Ramírez, Francisco José ^a   Argueta Manzano, Oscar Eusebio ^a   Galera Davidson, Hugo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP ABH ANTIGEN; BLOOD GROUP ANTIGEN; BLOOD GROUP B ANTIGEN; GLYCOPROTEIN; LECTIN RECEPTOR; PEANUT AGGLUTININ; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; LECTIN BINDING; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; METASTASIS; PROGNOSIS; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION;

ABO BLOOD-GROUP SYSTEM; ADENOCARCINOMA, FOLLICULAR; ADENOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0344110536     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Hakamori S-I. Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol. 1991;3:646-653.
2. Sell S. Cancer associated carbohydrates identified by monoclonal antibodies. Hum Pathol. 1990;21:1003-1019.
3. Hakomori S. Tumor malignancy defined by aberrant glycosilation and sphingo (glyco) lipid metabolism. Cancer Res. 1996;56:5309-5311.
4. King MJ. Blood group antigens on human erytrocytes - distribution, structure and possible functions. Biochim Biophys Acta. 1994;1997:15-44.
5. Szulman AE. The histological distribution of the blood group substances in man as disclosed by immunofluorescence: the A, B and H antigens in embryos and fetuses from 18 nm in length. J Exp Med. 1964;1192:503-515.
6. Vowden P, Lowe AD, Lennox ES, Bleehen NM. Thyroid blood group iso-antigen expression a parallel with abh isoantigen expression in the distal colon. Br J Cancer. 1986;53:721-725.
7. Vierbuchen M, Schröder S, Uhlenbruck G, Ortmann M, Fischer R. CA 50 and CA 19-9 antigen expression in normal, hyperplastic and neoplastic thyroid tissue. Lab Invest. 1989;60:726-732.
8. Vierbuchen M, Larena A, Schröder S, et al. Blood group antigen expression in medullary carcinoma of the thyroid: An immunohistochemical study on the occurrence of the type 1 chain-derived antigens. Virchows Arch B Cell Pathol. 1992;62:79-88.
9. Vierbuchen M, Schröder S, Larena A, Uhlenbruck C, Fischer R. Native and sialic acid masked Lewis(a) antigen reactivity in medullary thyroid carcinoma: distinct tumor-associated and prognostic relevant antigens. Virchows Arch. 1994; 424:205-211.
10. Ito N, Yokota M, Nagaike C, et al. Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland. Histochem J. 1996; 28:613-623.
11. González-Cámpora R, Montero C, Martín-Lacave I, Galera H. Demonstration of vascular endothelium in thyroid carcinomas using Ulex europaeus I agglutinin. Histopathology. 1986;10:261-266.
12. Oh-Uti K, Tohoku J. Polysacharides and a glycidamin in the tissue of gastric cancer. Exp Med. 1949;51:297.
13. Yonezawa S Tachikawa T, Shin S. Sialosyl-Tn antigen: its distribution in normal human tissues and expression in adenocarcinomas. Am I Clin Pathol. 1992;98:167-174.
14. Davidsohn I, Stejskal R, Lill P. The loss of isoantigens A, B, H in carcinoma of the urinary bladder. Lab Invest. 1973;28:382-388.
15. D'Elia FL, Cooper HS, Mulholland S. ABH isoantigens in stage O papillary transitional cell carcinoma of the bladder: correlation with biological behavior. J Urol. 1982;127:665-667.
16. Sheinfeld J, Reuter VE, Fair WR, Cordón-Cardo C. Expression of blood group antigens in bladder cancer: current concepts. Semin Surg Oncol. 1992;8: 308-315.
17. Sheinfeld J, Reuter VE, Sarkis AS, Cordon-Cardo C. Blood group antigens in normal and neoplastic urothelium. J Cell Biochem. 1992;161(suppl):50-55.
18. Yamada T, Fukui I, Kobayashi T, et al. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder. Cancer. 1991; 67:1661-1666.
19. Alvarez-Fernández E, Carretero-Albinana L. Expression of blood group antigens by normal bronchopulmonary tissues and common forms of pulmonary carcinomas. Arch Pathol Lab Med. 1991;115:42-49.
20. Bryne M, Thrane PS, Dabelsteen E. Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinoma. Cancer. 1990;66:2118-2123.
21. Lin F, Liu PI, McGregor DH. Isoantigens A, B and H in morphologically normal mucosa and in carcinoma of the larynx. Am J Clin Pathol. 1977;68:372-375.
22. Davidshon I, Ni LY, Stejskal R. Tissue isoantigens A, B and H in carcinoma of the stomach. Arch Pathol. 1971;92:456-464.
23. Lauwers CY, Melamed J, Rojas-Corona RR. Blood group antigens in Barrett's esophagus and associated adenocarcinomas. Mod Pathol. 1993;6:588-591.
24. y, A, B). Lab Invest. 1987;57:421-428.
25. Hasegawa H, Watanabe M, Arisawa Y, Teramoto T, Kodaira S, Kitajima M. Carbohydrate antigens and liver metastasis in colorectal cancer. Jpn J Clin Oncol. 1993;23:336-341.
26. Yuan M, Itzkowitz SH, Palekar A, et al. Distribution of blood group antigens A, B, H, Lewis a and Lewis b in human normal, fetal and malignant colonic tissue. Cancer Res. 1985;45:4499-4511.
27. Terada T, Nakanuma Y. Expression of ABH blood group antigens, receptors of Ulex europaeus agglutinin I, and factor VIII-related antigen on sinusoidal endothelial cells in adenomatous hyperplasia in human cirrhotic livers. Hum Pathol. 1991;22:486-493.
28. Minato H, Nakanuma Y, Terada T. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts. Histopathology. 1996;28:411-419.
29. Ichihara T, Sakamoto J, Nakao A, et al. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein. Cancer. 1993;71:71-81.
30. Sakamoto J, Kamada M, Irahama M, et al. Differences in clinical significance of blood group antigens A, B, and H in carcinoma tissue in the uterine cervix. Gynecol Oncol. 1989;25:195-203.
31. Leitao D, Sobrinho Simoes M, Bennett EP, et al. Biosynthetic basis of incompatible histo-blood group A antigen expression: anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Res. 1993;53: 5494-5500.
32. Yates AD, Watkins WM. The biosynthesis of blood group B determinants by the blood group A gene-specified a-3-n-acetyl-d-galactosaminyltransferase. Biochem Biophys Res Commun. 1982;109:958-965.
33. Clausen H, Hakomori S-I. ABH and related histo-blood group antigens: immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989;56:1-20.
34. Yamamoto F-I, Clausen H, White T, Hakomori S-I. Mollecular genetic basis of the histo-blood group ABO system. Nature. 1990;345:229-233.
35. Murata K, Egami H, Shibata Y. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, CA 19-9 and CSLEX 1 in early cancer intestinal metaplasia and uninvolved mucosa of the stomach. Am J Clin Pathol. 1992;98:67-75.
36. Torrado J, Blasco E, Gutierrez-Hoyos A, Cosme A, Lojendio M, Arenas JI. Lewis system alterations in gastric carcinogenesis. Cancer. 1990;66:1769-1774.
37. Ravn V, Mandel U, Svenstrup B, Dabelsteen E. Type-1 chain histo-blood group antigens [Le(a), monosialosyl-Le(a), disialosyl-Le(a), Le(b), and H] in normal and malignant human endometrium. Virchows Arch. 1994;424:495-502.
38. Juhl BR, Hartvig Hartzen S, Hainau B. Lewis A antigen in transitional cell tumors of the urinary bladder. Cancer. 1986;58:222-228.
39. Idikio HA, Manichavel V. Lewis blood group antigens (A and B) in human breast tissues: loss of Lewis b in breast cancer cells and correlation with tumor grade. Cancer. 1991;68:1303-1308.
40. Narita T, Funahashi H, Satoh Y, Watanabe T, Oto I, Takagi H. Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer. 1993;71:3044-3053.
41. y antigen expression in human pancreatic cancer. Cancer Res. 1988;45:475-482.
42. Asai S, Watanabe T, Sakamoto J, et al. Expression and prognostic indicators of type and type 2 Lewis blood group antigens in colorectal cancers. Nippon Geka Gakkai Zasshi. 1994;95:753-762.
43. Hoff SD, Irimura T, Matsushita Y, Ota DM, Cleary HR, Hakomori S-I. Metastatic potential of colon carcinoma: expression of ABO/Lewis-related antigens. Arch Surg. 1990;125:206-209.
44. x antigen in relation to survival of patients with colorectal carcinoma. Cancer. 1993;72:2323-2330.
45. Ogawa J, Sano A, Inoue H, Koide S. Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer. Ann Thorac Surg. 1995;59: 412-415.
46. Shimizu T, Yonezawa S, Tanaka S, Sato E. Expression of Lewis X-related antigens in adenocarcinomas of lung. Histopathology. 1993;22:549-555.
47. Martensson S, Bigler SA, Brown M, Lange PH, Brawer MK, Hakomori S. Sialyl-Lewis(X) and related carbohydrate antigens in the prostate. Hum Pathol. 1995;26:735-739.
48. Ohshio G, Yoshioka H, Manabe T, et al. Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract. J Cancer Res Clin Oncol. 1994;120:325-330.
49. Ching CK, Holmes SW, Holmes GK, Long RG. Blood-group sialyl Tn antigen is more specific than Tn as a tumor marker in pancreas. Pancreas. 1994;9: 698-702.
50. Itzkowitz SH, Marshall A, Kornbluth A, et al. Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis. Gastroenterology. 1995;109:490-497.
51. Hamada S, Furumoto H, Kamada M, Hirao T, Aono T. High expression rate of Tn antigen in metastatic lesions of uterine cervical cancers. Cancer Lett. 1993; 74:167-173.
52. Osako M, Yonezawa S, Siddiki B, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer. 1993;71:2192-2199.
53. Miles DW, Linehan J, Smith P, Filipe I. Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors. Br J Cancer. 1995;71:1074-1076.
54. Ma XC, Terata N, Kodama M, Jancic S, Hosokawa Y, Hattori T. Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas. Eur J Cancer. 1993;29A:1820-1823.
55. Blasco E, Torrado J, Belloso L, Arocena F, Gutierrez-Hoyos A, Cuadrado E. T-antigen: a prognostic indicator of high recurrence index in transitional carcinoma of the bladder. Cancer. 1988;61:1091-1095.
56. Coon JS, Weinstein RS, Summers JL. Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol. 1992;87:692-699.
57. Cordón-Cardo C, Lloyd KO, Finstad CL, et al. Immunoanatomic distribution of blood group antigens in the human urinary tract. Lab Invest. 1986;55: 444-454.
58. Ghazizadeh M, Oguro Y, Sasaki Y, Aihara K, Araki T, Springer GF. Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors. Am J Clin Pathol. 1990;93:315-321.
59. Moorhen M, Carpenter F. Peanut lectin: a histochemical marker for pheochromocytomas. Virchows Arch A Pathol Anal 1991;419:203-207.
60. Langkilde NC, Wolf H, Clausen H, Ornoft TF. Human urinary bladder carcinoma glycoconjugates expressingT-(Gal beta(1-3)GaINAc alpha 1-O-R)and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies. Cancer Res. 1992;52:5030-5036.